Evidence map›Paper›PMID 25538615›Full record

ArticleFrontiers in aging neuroscience2014

Detection of bacterial antigens and Alzheimer's disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae.

Christopher S Little, Timothy A Joyce, Christine J Hammond, Hazem Matta, David Cahn, Denah M Appelt, Brian J Balin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Brain, behavior, & immunity - health · 2025
    Article
  3. Review
  4. Infections withFrontiers in aging neuroscience · 2025
    Review
  5. Review
  6. Article
  7. Frontiers in neuroscience · 2024
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Christopher S LittleDepartment of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine Philadelphia, PA USA ; Center for Chronic Disorders of Aging, Philadelphia College of Osteopathic Medicine Philadelphia, PA, USA.
Timothy A JoyceDepartment of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine Philadelphia, PA USA ; Center for Chronic Disorders of Aging, Philadelphia College of Osteopathic Medicine Philadelphia, PA, USA.
Christine J HammondCenter for Chronic Disorders of Aging, Philadelphia College of Osteopathic Medicine Philadelphia, PA, USA ; Division of Research, Philadelphia College of Osteopathic Medicine Philadelphia, PA, USA.
Hazem MattaCenter for Chronic Disorders of Aging, Philadelphia College of Osteopathic Medicine Philadelphia, PA, USA.
David CahnCenter for Chronic Disorders of Aging, Philadelphia College of Osteopathic Medicine Philadelphia, PA, USA.
Denah M AppeltDepartment of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine Philadelphia, PA USA ; Center for Chronic Disorders of Aging, Philadelphia College of Osteopathic Medicine Philadelphia, PA, USA.
Brian J BalinDepartment of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine Philadelphia, PA USA ; Center for Chronic Disorders of Aging, Philadelphia College of Osteopathic Medicine Philadelphia, PA, USA.
Philadelphia College of Osteopathic Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathology consistent with that observed in Alzheimer's disease (AD) has previously been documented following intranasal infection of normal wild-type mice with Chlamydia pneumoniae (Cpn) isolated from an AD brain (96-41). In the current study, BALB/c mice were intranasally infected with a laboratory strain of Cpn, AR-39, and brain and olfactory bulbs were obtained at 1-4 months post-infection (pi). Immunohistochemistry for amyloid beta or Cpn antigens was performed on sections from brains of infected or mock-infected mice. Chlamydia-specific immunolabeling was identified in olfactory bulb tissues and in cerebrum of AR-39 infected mice. The Cpn specific labeling was most prominent at 1 month pi and the greatest burden of amyloid deposition was noted at 2 months pi, whereas both decreased at 3 and 4 months. Viable Cpn was recovered from olfactory bulbs of 3 of 3 experimentally infected mice at 1 and 3 months pi, and in 2 of 3 mice at 4 months pi. In contrast, in cortical tissues of infected mice at 1 and 4 months pi no viable organism was obtained. At 3 months pi, only 1 of 3 mice had a measurable burden of viable Cpn from the cortical tissues. Mock-infected mice (0 of 3) had no detectable Cpn in either olfactory bulbs or cortical tissues. These data indicate that the AR-39 isolate of Cpn establishes a limited infection predominantly in the olfactory bulbs of BALB/c mice. Although infection with the laboratory strain of Cpn promotes deposition of amyloid beta, this appears to resolve following reduction of the Cpn antigen burden over time. Our data suggest that infection with the AR-39 laboratory isolate of Cpn results in a different course of amyloid beta deposition and ultimate resolution than that observed following infection with the human AD-brain Cpn isolate, 96-41. These data further support that there may be differences, possibly in virulence factors, between Cpn isolates in the generation of sustainable AD pathology.

Indexed as

Alzheimeramyloid betabacteriaChlamydia pneumoniaeinfection

Identifiers

PMID25538615
PMCPMC4257355
OpenAlexW2080023640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.